Single-agent rituximab for primary CNS lymphoma during pregnancy as a bridge to definitive management. [electronic resource]
Producer: 20140421Description: e14-7 p. digitalISSN:- 1527-7755
- Adult
- Antibodies, Monoclonal, Murine-Derived -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Biopsy
- Brain -- pathology
- Carmustine -- administration & dosage
- Central Nervous System Neoplasms -- diagnosis
- Cesarean Section
- Cytarabine -- administration & dosage
- Dexamethasone -- administration & dosage
- Drug Administration Schedule
- Female
- Hematopoietic Stem Cell Transplantation
- Humans
- Lymphoma, Large B-Cell, Diffuse -- diagnosis
- Magnetic Resonance Imaging
- Melphalan -- administration & dosage
- Methotrexate -- administration & dosage
- Podophyllotoxin -- administration & dosage
- Pregnancy
- Pregnancy Complications, Neoplastic -- diagnosis
- Pregnancy Outcome
- Rituximab
- Transplantation, Autologous
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.